11/15
Cancer Research
Proton therapy side-effects found fewer than conventional radiation
Proton therapy side-effects found fewer than conventional radiation
In the largest study of its kind, Penn researchers compare overall adverse events of proton and photon therapies.
Compound’s benefits aren’t tied to the body clock
Compound’s benefits aren’t tied to the body clock
New research from Penn Medicine overturns what was previously known about a compound associated with reductions in obesity and diabetes risk.
Cancer screening rates decline when patients see doctors later in day
Cancer screening rates decline when patients see doctors later in day
Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the day goes on, according to a new study from researchers in the Perelman School of Medicine and Wharton School.
The cancer-body clock connection
The cancer-body clock connection
Researchers at the Perelman School of Medicine show how disruptions to the circadian rhythm influence tumor growth and cancer treatment.
Two Penn faculty elected to the National Academy of Sciences
Two Penn faculty elected to the National Academy of Sciences
Eugene Mele of the School of Arts and Sciences and Nancy Speck of the Perelman School of Medicine are welcomed into the Academy for their “distinguished and continuing achievements in original research.”
Expanding opportunities to leverage science in the clinic
Expanding opportunities to leverage science in the clinic
Patricia Corby, who recently joined the School of Dental Medicine as associate dean for translational research, is bringing her research to bear for cancer patients undergoing radiation, while looking to advance clinical research School-wide.
Topical targeted therapies show promise in treatment of skin cancer
Topical targeted therapies show promise in treatment of skin cancer
A Penn study finds fewer side effects with small-molecule kinase inhibitors compared to standard ointment when treating precancerous skin lesions.
The Power of Penn at the Met
The Power of Penn at the Met
One year into the Power of Penn campaign, President Amy Gutmann hosted a panel discussion with three professors to usher in another year of inclusion, innovation, and impact on a local and global scale.
Cancer most frequently spreads to the liver. Here’s why.
Cancer most frequently spreads to the liver. Here’s why.
Researchers from the Abramson Cancer Center shows hepatocytes, the chief functional cells of the liver, orchestrate the “seed and soil” process for cancer to spread to the liver.
For melanoma patients, one dose of immunotherapy before surgery can lead to remission
For melanoma patients, one dose of immunotherapy before surgery can lead to remission
An Abramson Cancer Center study finds that with a single dose of a PD-1 inhibitor, immune responses can peak in just one week.
In the News
Forbes
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Philadelphia Inquirer
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
PhillyVoice
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
The New York Times
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
Today
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →
Stat
New immunotherapy combination could ‘change the landscape’ of cancer treatment
A study by Andy Minn and postdoc Divij Mathew of the Perelman School of Medicine and colleagues found that a combination checkpoint inhibitor therapy benefited patients with lung cancer.
FULL STORY →